Andrew T. Mcbride

Glasgow, SCT G128LT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Plane stress finite element modelling of arbitrary compressible hyperelastic materials.

Plane stress finite element modelling of arbitrary compressible hyperelastic materials.

Journal: Acta mechanica

Published: October 28, 2024

A novel micromorphic approach captures non-locality in continuum bone remodelling.

A novel micromorphic approach captures non-locality in continuum bone remodelling.

Journal: Computer methods in biomechanics and biomedical engineering

Published: June 15, 2023

The role of shear dynamics in biofilm formation.

The role of shear dynamics in biofilm formation.

Journal: NPJ biofilms and microbiomes

Published: October 19, 2021

Exploring N-acyl-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-enes as 11β-HSD1 Inhibitors.

Exploring N-acyl-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-enes as 11β-HSD1 Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: January 29, 2018

Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.

Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.

Journal: Biochemical pharmacology

Published: October 26, 2017

Microstructurally-based constitutive modelling of the skin - Linking intrinsic ageing to microstructural parameters.

Microstructurally-based constitutive modelling of the skin - Linking intrinsic ageing to microstructural parameters.

Journal: Journal of theoretical biology

Published: September 12, 2017

Design, synthesis and in vivo study of novel pyrrolidine-based 11β-HSD1 inhibitors for age-related cognitive dysfunction.

Design, synthesis and in vivo study of novel pyrrolidine-based 11β-HSD1 inhibitors for age-related cognitive dysfunction.

Journal: European journal of medicinal chemistry

Published: June 25, 2017

In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.

In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.

Journal: Scientific reports

Published: May 15, 2017

A validated patient-specific FSI model for vascular access in haemodialysis.

A validated patient-specific FSI model for vascular access in haemodialysis.

Journal: Biomechanics and modeling in mechanobiology

Published: April 24, 2017

Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis.

Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis.

Journal: Journal of medicinal chemistry

Published: April 12, 2017

The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.

The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.

Journal: Bioorganic & medicinal chemistry letters

Published: January 09, 2017

Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™).

Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™).

Journal: British journal of pharmacology

Published: August 23, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026